Efficacy and safety of chronomodulated chemotherapy for patients with metastatic colorectal cancer: a systematic review and meta-analysis

Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion

(2015) Gini F Fleming et al.   BMC CANCER

The circadian timing system in clinical oncology

(2014) Pasquale F. Innominato et al.   ANNALS OF MEDICINE

Incidence and survival in late liver metastases of colorectal cancer

(2014) Pierre Landreau et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Circadian molecular clocks and cancer

(2013) Fergal C. Kelleher et al.   CANCER LETTERS

Time Recall; Future Concept of Chronomodulating Chemotherapy for Cancer

(2013) Paul Zarogoulidis et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis

(2012) S. Giacchetti et al.   ANNALS OF ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Circadian Timing in Cancer Treatments

(2010) Francis Lévi et al.   Annual Review of Pharmacology and Toxicology

Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability

(2010) Francis Lévi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Circadian clock control of the cellular response to DNA damage

(2010) Aziz Sancar et al.   FEBS LETTERS

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

(2010) Jean-Yves Douillard et al.   JOURNAL OF CLINICAL ONCOLOGY

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

(2010) David Moher et al.   International Journal of Surgery

A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer

(2009) C. Qvortrup et al.   ANNALS OF ONCOLOGY

A Four-Arm, Randomized, Multicenter Phase II Trial of Oxaliplatin Combined with Varying Schedules of 5-Fluorouracil as First-line Therapy in Previously Untreated Advanced Colorectal Cancer

(2008) Ramesh K. Ramanathan et al.   Clinical Colorectal Cancer

The influence of circadian rhythms on the kinetics of drugs in humans

(2008) Massimo Baraldo   Expert Opinion on Drug Metabolism & Toxicology